Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCC3 | O15438 | 2/20 | 0.34 |
| ▸ | ABCC4 | O15439 | 2/20 | 0.34 |
| ▸ | SLCO1B3 | Q9NPD5 | 2/20 | 0.34 |
| ▸ | SLCO1B1 | Q9Y6L6 | 2/20 | 0.34 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.34 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.34 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.31 |
| ▸ | TGFBR2 | P37173 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24982985 | 0.84 | SLCO1B1 (0.39) | ABCC3ABCC4SLCO1B3SLCO1B1ABCB11 | |
| SCHEMBL19715620 | 0.83 | DGAT1 (0.38) | SLCO1B1ABCB11 | |
| SCHEMBL29411759 | 0.82 | SLCO1B1 (0.38) | ABCC3ABCC4SLCO1B3SLCO1B1ABCB11 | |
| SCHEMBL19715757 | 0.82 | SLCO1B1 (0.38) | ABCC3ABCC4SLCO1B3SLCO1B1ABCB11 | |
| SCHEMBL19715601 | 0.82 | SLCO1B1 (0.36) | ABCC3ABCC4SLCO1B3SLCO1B1ABCB11 | |
| SCHEMBL29068133 | 0.81 | SLCO1B1 (0.37) | ABCC3ABCC4SLCO1B3SLCO1B1ABCB11 | |
| SCHEMBL30452478 | 0.81 | SLCO1B1 (0.36) | ABCC3ABCC4SLCO1B3SLCO1B1ABCB11 | |
| SCHEMBL29068103 | 0.81 | SLCO1B1 (0.36) | ABCC3ABCC4SLCO1B3SLCO1B1ABCB11 | |
| SCHEMBL25422658 | 0.81 | SLCO1B1 (0.37) | ABCC3ABCC4SLCO1B3SLCO1B1ABCB11 | |
| SCHEMBL21107828 | 0.78 | KDM4C (0.31) | SLCO1B1LPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250230140-A1 | NOVEL TRIAZOLE-PYRIDINE SUBSTITUTED PYRROLIDINYL AND TETRAHYDRO-2H-PYRANYL ACETIC ACID COMPOUNDS AS LPA ANTAGONISTS | VIVA STAR BIOSCIENCES (SUZHOU) CO., LTD. (CN) | 2025-07-17 | — | — | US | disclosed |
| EP-4330249-A1 | NOVEL TRIAZOLE-PYRIDINE SUBSTITUTED PYRROLIDINYL AND TETRAHYDRO-2H-PYRANYL ACETIC ACID COMPOUNDS AS LPA ANTAGONISTS | Viva Star Biosciences (Suzhou) Co., Ltd. (CN) | 2024-03-06 | — | — | EP | disclosed |
| WO-2022232459-A1 | NOVEL TRIAZOLE-PYRIDINE SUBSTITUTED PYRROLIDINYL AND TETRAHYDRO-2H-PYRANYL ACETIC ACID COMPOUNDS AS LPA ANTAGONISTS | VIVA STAR BIOSCIENCES (SUZHOU) CO., LTD. (CN) | 2022-11-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250230140-A1 | NOVEL TRIAZOLE-PYRIDINE SUBSTITUTED PYRROLIDINYL AND TETRAHYDRO-2H-PYRANYL ACETIC ACID COMPOUNDS AS LPA ANTAGONISTS | LPAR3, LPAR2, LPAR1 | ABCC3 3071/4885ABCC4 3605/4885SLCO1B3 4178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.